This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

WomanCare Global Signs Agreement With Conceptus, Inc. For Exclusive Distribution Of Essure®

Permanent Contraception in Ghana, Kenya, Mexico, Puerto Rico, and Turkey

CHAPEL HILL, N.C., Jan. 10, 2011 /PRNewswire-USNewswire/ -- WomanCare Global is pleased to announce an expansion of their product portfolio to include Essure®, a non-surgical permanent birth control and the most effective permanent contraceptive method on the market.  WomanCare Global will provide full sales, marketing, training and distribution of Essure in Ghana, Kenya, Mexico, Puerto Rico and Turkey.  It is anticipated that additional countries will be added in the future.

(Logo: http://photos.prnewswire.com/prnh/20101018/DC83896LOGO)

" Essure is an excellent method of permanent contraception.  The procedure is quick and easy and avoids the risk of anesthesia and abdominal surgery while providing effective permanent contraception.  Now that this method has been available in the US and Europe for many years, we are excited about expanding access to this proven method," said Matthew Reeves, MD, MPH, WomanCare Global's Vice President, Medical Affairs.  " I have been performing Essure procedures in the US for more than 5 years and look forward to introducing healthcare providers in other countries to the Essure procedure."

" WomanCare Global realizes the critical importance of creating global access to innovative reproductive healthcare products.  When you provide women with reproductive choices, you provide them with freedom and security for a strong future.  Essure clearly fills this need," said WomanCare Global Chief Operating Officer Saundra Pelletier.  " Our organization's hybrid business model allows us the flexibility to cross-subsidize products and results in the creation of true access in both developed and developing countries."  

Kathryn Tunstall, Founder and Chairman of the Board at Conceptus states, " We have a shared vision with WomanCare Global, that all women should have access to improved methods of birth control, such as Essure.  We are delighted to partner with WomanCare Global to ensure that this vision is realized."

About the Essure Procedure

The Essure procedure, FDA approved since 2002, is the first permanent birth control method that can be performed in the comfort of a physician's office in less than 10 minutes (average hysteroscopic time) without hormones, cutting, burning or the risks associated with general anesthesia or tubal ligation. Soft, flexible inserts are placed in a woman's fallopian tubes through the cervix without incisions. Over the next three months, the body forms a natural barrier around the micro-inserts to prevent sperm from reaching the egg. The Essure procedure is 99.95% effective based on one year of follow up with zero pregnancies reported in clinical trials, making it the most effective form of permanent birth control on the market. The procedure is covered by most insurance plans, and when it is performed in a doctor's office the cost to the patient may be as low as a simple co-pay.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,080.14 +21.45 0.12%
S&P 500 2,117.69 +4.76 0.23%
NASDAQ 5,092.0850 +36.0220 0.71%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs